0001950047-24-003913.txt : 20240520 0001950047-24-003913.hdr.sgml : 20240520 20240520162107 ACCESSION NUMBER: 0001950047-24-003913 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240520 DATE AS OF CHANGE: 20240520 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Stoke Therapeutics, Inc. CENTRAL INDEX KEY: 0001623526 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 471144582 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-38938 FILM NUMBER: 24964816 BUSINESS ADDRESS: STREET 1: 45 WIGGINS AVENUE CITY: BEDFORD STATE: MA ZIP: 01730 BUSINESS PHONE: 781-430-8200 MAIL ADDRESS: STREET 1: 45 WIGGINS AVENUE CITY: BEDFORD STATE: MA ZIP: 01730 FORMER COMPANY: FORMER CONFORMED NAME: ASOthera Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20141028 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Kaye Edward M. MD CENTRAL INDEX KEY: 0001522780 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: 3450 MONTE VILLA PARKWAY CITY: BOTHELL STATE: WA ZIP: 98011 144 1 primary_doc.xml 144 0001522780 XXXXXXXX LIVE 0001623526 STOKE THERAPEUTICS INC 001-38938 45 Wiggins Ave Bedford MA 01730 7814308200 EDWARD M KAYE Director Officer COMMON Morgan Stanley Smith Barney LLC Executive Financial Services

1 New York Plaza 8th Floor New York NY 10004

42350 588665.00 52119860 05/20/2024 NASDAQ Common 05/25/2022 Previously Exercised Stock Options Issuer N 8000 05/25/2022 Cash Common 03/15/2024 Restricted Stock Units Issuer N 24350 03/15/2024 N/A Common 12/30/2020 Previously Exercised Stock Options Issuer N 10000 12/30/2020 Cash Y 05/20/2024 12/26/2023 /s/ Edward Michael Kaye